Clinical Trials Learning Sessions
PHEN provides Clinical Trial Learning Sessions in conjunction with cancer centers to bring Black patients and clinical trial doctors together to learn about clinical trials, and to build trust around clinical trial participation.
Pfizer
Clinical Trials Learning Session
Clinical trials are an essential way for patients with advanced prostate cancer to get treatment. In collaboration with Pfizer Pharmaceuticals, PHEN hosted a clinical trial learning session on this topic. This learning session highlighted three coordinated Phase 3 trials that test a twice-daily oral pill (EZH2 inhibitor) added to today’s standard of care for men with metastatic castration‑resistant prostate cancer.
These trials aimed to determine if combining the EZH2 inhibitor with treatments such as enzalutamide could delay resistance and prolong the time before the cancer worsens. The trials are randomized. Every participant continues to receive complete standard treatment.
Dr. Keith Crawford, PHEN’s Director of Clinical Trials and Patient Education, spoke with Dr. Neal Shore, Medical Director of the Carolina Urological Research Center. They discussed who may qualify, how often visits occur, common side effects, and why diverse participation is important.
Men with metastatic prostate cancer and their caregivers should view this session. They can learn how these clinical trials work, what to expect, and how to check eligibility with their care team.
Bayer
Clinical Trials Learning Session
Cancer recurrence can be a significant concern for prostate cancer survivors and their caregivers. In collaboration with Bayer Pharmaceutical, PHEN hosted a clinical trial learning session on this topic, an educational event to teach patients about the principles, processes, and practices involved in conducting and participating in clinical trials.
The focus of this learning session was the ARASTEP clinical trial, a trial aimed at determining if the combination of Darolutamide and ADT prolongs the time that patients with a prostate cancer biochemical recurrence live without their cancer getting worse (progressing).
Dr. Keith Crawford, PHEN’s Director of Clinical Trials and Patient Education, is joined by Dr. Emmanuel S. Antonarakis, Professor of Medicine from the University of Minnesota, in a fireside chat discussion about the ARASTEP study and how patients can participate.
Prostate cancer patients with a rising PSA should view this recorded learning session to learn about the potential benefits of participating in the ARASTEP clinical trial.
Duke Cancer Institute
Clinical Trials Learning Session
Duke Cancer Institute physicians and the Prostate Health Education Network (PHEN) present a virtual session to learn about clinical trial opportunities available at Duke.
Johns Hopkins University
Clinical Trials Learning Session
Physicians from the Johns Hopkins University School of Medicine partner with PHEN to hold a virtual webinar and discuss clinical trial opportunities found at Johns Hopkins.
MSKCC
Clinical Trials Learning Session
Memorial Sloan Kettering Cancer Center’s physicians partnered with PHEN to present a virtual learning session about clinical trial opportunities available at MSKCC.
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.